Anesthetic management using an i-gelTM supraglottic airway for a pediatric patient with Hunter syndrome-a case report

Mucopolysaccharidoses (MPS) are a group of inherited, metabolic disorders caused by a lack of lysosomal enzymes. Among the various types of MPS, Hunter syndrome (MPS type II) is a rare X-linked disorder in which patients lack the lysosomal enzyme iduronate-2-sulfatase (IDS), which leads to the accumulation of glycosaminoglycans (CAGs). This can be a great concern to the anesthesiologist due to the involvement of several regions related to airway management. Here, we report a case of successful anesthetic management using a size 2 i-gelTM supraglottic airway in a 5-year-old child with non-suppurative otitis media and middle ear effusion who arrived at our operating room for myringotomy with ventilation tube insertion.